KeyBank National Association
ARQT icon

KeyBank National Association’s Arcutis Biotherapeutics ARQT Stock Holding History

KeyBank National Association’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$541K Sell
22,952
-7,931
-26% -$202K ﹤0.01% 797
2025
Q4 		$897K Sell
30,883
-14,132
-31% -$362K ﹤0.01% 608
2025
Q3 		$849K Sell
45,015
-1,500
-3% -$23.7K ﹤0.01% 617
2025
Q2 		$652K Hold
46,515
– – ﹤0.01% 687
2025
Q1 		$727K Sell
46,515
-5,689
-11% -$80.1K ﹤0.01% 627
2024
Q4 		$727K Buy
52,204
+9,680
+23% +$106K ﹤0.01% 649
2024
Q3 		$395K Hold
42,524
– – ﹤0.01% 879
2024
Q2 		$395K Hold
42,524
– – ﹤0.01% 831
2024
Q1 		$421K Buy
42,524
+7,300
+21% +$54.5K ﹤0.01% 817
2023
Q4 		$114K Buy
35,224
+22,195
+170% +$60.3K ﹤0.01% 1058
2023
Q3 		$69.2K Hold
13,029
– – ﹤0.01% 1016
2023
Q2 		$124K Buy
+13,029
New +$145K ﹤0.01% 1033

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return